You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 22, 2025

Drug Price Trends for VANCOMYCIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for VANCOMYCIN

Best Wholesale Price for VANCOMYCIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
VANCOMYCIN HCL 750MG/VIL INJ Mylan Institutional LLC 67457-0705-75 10 57.38 5.73800 EACH 2024-01-01 - 2028-09-28 FSS
VANCOMYCIN HCL 1.5GM/VIL INJ Mylan Institutional LLC 67457-0824-99 1x10 112.29 2023-09-29 - 2028-09-28 FSS
VANCOMYCIN HCL 1.25GM/VIL INJ Mylan Institutional LLC 67457-0823-99 1x10 142.54 2023-09-29 - 2028-09-28 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Vancomycin Market Analysis and Price Projections

Introduction to Vancomycin

Vancomycin is a glycopeptide antibiotic widely used to treat severe bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). Its efficacy and broad spectrum of activity against gram-positive bacteria make it a crucial component in the antibiotic arsenal.

Current Market Size and Growth

The global vancomycin market has been experiencing rapid growth in recent years. Here are some key statistics:

  • 2023 Market Size: The global vancomycin market was estimated at $0.74 billion in 2023[1].
  • 2024 Projections: It is expected to grow to $0.82 billion in 2024, with a compound annual growth rate (CAGR) of 11%[1].
  • Long-Term Projections: By 2028, the market is forecasted to reach $1.26 billion at a CAGR of 11.3%[1].

Regional Market Analysis

The vancomycin market is diverse and growing across various regions:

  • North America: This region is expected to hold a significant share of the global market, driven by rising VRSA infections, increased R&D initiatives, and high demand for new treatments. The U.S. market was valued at $84.5 million in 2020 and is anticipated to rise at the highest CAGR over the forecast period[5].
  • China: The Chinese market is projected to grow at a CAGR of 9.4% from 2021 to 2027, reaching a valuation of $102.3 million by 2027. This growth is fueled by government initiatives for infection control, a growing population, and increased healthcare awareness[5].
  • Europe: Countries like Germany are also seeing significant growth, with the German market projected to rise at a CAGR of 4% over the forecast period[2].

Drivers of Market Growth

Several factors are driving the growth of the vancomycin market:

  • Increasing Prevalence of Infectious Diseases: The rise in antibiotic-resistant infections, such as MRSA, has increased the demand for effective antibiotics like vancomycin[5].
  • Government Initiatives: Government-funded programs for disease surveillance and infection control measures are supporting market growth[1].
  • Advancements in Diagnostic Technologies: The adoption of advanced diagnostic technologies, including miniaturization and portability of diagnostic devices, multiplex assays, and next-generation sequencing (NGS), is enhancing the detection and treatment of infections[1].
  • Integration of Digital Health Solutions: The integration of digital health solutions for efficient data management and the use of AI and machine learning algorithms in diagnostic platforms are further boosting the market[1].

Market Segmentation

The vancomycin market can be segmented based on application and end-user:

  • Applications: Key applications include antibacterial treatments, dialysis care, and surgical prophylaxis. The lung infection application segment is expected to reach $201.9 million by 2030 with a CAGR of 6.1%, while the sepsis application segment is set to grow at a 5.1% CAGR over the same period[3].
  • End-Users: Major end-users include hospitals, ambulatory surgical centers, and clinics. Hospitals are a significant segment due to the greater utilization of vancomycin in hospital settings for severe infections[4].

Competitive Landscape

The vancomycin market is competitive, with several key players:

  • Alvogen
  • MGB Biopharma Limited
  • Oragenics
  • Aphios Corporation
  • Microbiotix

These companies are involved in continuous research and development to improve formulations and applications of vancomycin[5].

Price Projections

The pricing of vancomycin can vary based on several factors, including region, formulation, and distribution channels. Here are some general trends:

  • Global Market Value: The global market value is projected to increase from $313.7 million in 2020 to $465.1 million by 2027, indicating a steady rise in demand and potentially stable or increasing prices[5].
  • Regional Pricing: In the U.S., the market was valued at $84.5 million in 2020 and is expected to grow significantly, which could influence pricing due to increased demand and healthcare spending[5].

Key Takeaways

  • The global vancomycin market is experiencing rapid growth driven by the increasing prevalence of infectious diseases and advancements in diagnostic technologies.
  • North America and China are key regions driving market growth.
  • The market is segmented into various applications and end-users, with hospitals being a major segment.
  • Continuous R&D and integration of digital health solutions are expected to sustain market expansion.

FAQs

1. What is the current market size of the vancomycin market? The global vancomycin market was estimated at $0.74 billion in 2023[1].

2. What is the projected growth rate of the vancomycin market? The market is expected to grow at a CAGR of 11.3% from 2023 to 2028[1].

3. Which regions are driving the growth of the vancomycin market? North America and China are significant regions driving market growth, with the U.S. and Chinese markets expected to see substantial expansion[5].

4. What are the key applications of vancomycin? Key applications include antibacterial treatments, dialysis care, and surgical prophylaxis[4].

5. Who are the major players in the vancomycin market? Major players include Alvogen, MGB Biopharma Limited, Oragenics, Aphios Corporation, and Microbiotix[5].

Sources

  1. Research and Markets: Vancomycin Global Market Report 2024
  2. Fact.MR: Vancomycin Market to Expand around 1.5X by 2027
  3. GlobeNewswire: Vancomycin Markets - Global Strategic Business Report Q4, 2024
  4. 360iResearch: Vancomycin Market Size & Share 2025-2030
  5. Fact.MR: Vancomycin Market Size, Share Global Trajectory - 2027
Last updated: 2024-12-30

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.